Efficacy and Safety Associated With Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma
Author:
Affiliation:
1. Department of Gastrointestinal Medical Oncology, Oncoclínicas, Belo Horizonte, Brazil
2. Oncoclínicas, Salvador, Brazil
3. Oncoclínicas, Rio de Janeiro, Brazil
4. Oncoclínicas, Porto Alegre, Brazil
5. Oncoclínicas, São Paulo, Brazil
Publisher
American Medical Association (AMA)
Subject
General Medicine
Link
https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2786903/jcome_2021_oi_211017_1638202877.24539.pdf
Reference25 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.;Bray;CA Cancer J Clin,2018
2. Cancer statistics, 2020.;Siegel;CA Cancer J Clin,2020
3. Sorafenib in advanced hepatocellular carcinoma.;Llovet;N Engl J Med,2008
4. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial.;Kudo;Lancet,2018
5. Donafenib versus sorafenib in first-line treatment of unresectable or metastatic hepatocellular carcinoma: a randomized, open-label, parallel-controlled phase II-III trial.;Qin;J Clin Oncol,2021
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Network medicine analysis for dissecting the therapeutic mechanism of consensus TCM formulae in treating hepatocellular carcinoma with different TCM syndromes;Frontiers in Endocrinology;2024-08-15
2. Induction chemotherapy regimes in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: A network meta-analysis and cost-effectiveness analysis;Oral Oncology;2024-07
3. Development and Validation of a Prediction Model for Thyroid Dysfunction in Patients During Immunotherapy;Endocrine Practice;2024-07
4. Identification of VEGFs-related gene signature for predicting microangiogenesis and hepatocellular carcinoma prognosis;Aging;2024-06-13
5. Comparison of Efficacy and Safety between Immune Checkpoint Inhibitors and Targeted Drugs in Unresectable Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis;Combinatorial Chemistry & High Throughput Screening;2024-06-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3